120 results
Page 3 of 6
8-K
EX-99.1
oh1vzxnjnjmhnfjneb
10 Jun 22
InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector
4:36pm
8-K
EX-4.2
2ehffswmvey9tton
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
uop1o qse
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
6o4xc0 i7xpv2
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
jya2r0fsa
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.3
nyoerwc1g8
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
e1y0518
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
uer3ri3i0kbzcdet5
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
nei5bt p7gk7vf8x
25 Apr 22
Prospectus supplement
5:02pm
424B3
ymi1ex392y5
7 Apr 22
Prospectus supplement
4:46pm
8-K
EX-10.1
kbwhorp50p9qfwj m6l
22 Mar 22
Entry into a Material Definitive Agreement
6:05am
S-3
bchh nb3ohtgac5aweb
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.1
5fcrs6
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
d0c wj4zuame556m
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
gy6ry1sysihc1y0jp
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
0t0agt3f03tx
24 Sep 21
Annual report
7:31am
10-K
EX-4.7
up8r6i5 gjn1393
24 Sep 21
Annual report
7:31am